---
title: "002653.SZ (002653.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002653.SZ/news.md"
symbol: "002653.SZ"
name: "002653.SZ"
parent: "https://longbridge.com/en/quote/002653.SZ.md"
datetime: "2026-03-10T04:22:32.694Z"
locales:
  - [en](https://longbridge.com/en/quote/002653.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002653.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002653.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002653.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002653.SZ/news.md)


# 002653.SZ (002653.SZ) — Related News

### [Haisco Pharmaceutical Gets Marketing Approval For Rare Blood Disorder Drug](https://longbridge.com/en/news/278323248.md)
*2026-03-09T04:00:56.000Z*
> Haisco Pharmaceutical Gets Marketing Approval For Rare Blood Disorder Drug

### [Healthcare Industry Daily (03.08): Breakthroughs in Pharmaceutical Innovation](https://longbridge.com/en/news/278277902.md)
*2026-03-08T19:15:16.000Z*
> Asieris' APL-1702 (Xiwetai) has been approved for market launch, becoming the world's first non-invasive treatment produ

### [Haisco has obtained the marketing authorization acceptance notice for the innovative drug HSK39297 tablets](https://longbridge.com/en/news/278254470.md)
*2026-03-08T07:53:05.000Z*
> Haisco's subsidiary Sichuan Haisco Pharmaceutical Co., Ltd. recently received the Acceptance Notification HSK39297 issue

### [Haisco Pharmaceutical's Subsidiary Gets Nod to Trial Respiratory Disease Drug; Shares Up 4%](https://longbridge.com/en/news/278028183.md)
*2026-03-06T04:58:47.000Z*
> Haisco Pharmaceutical's Subsidiary Gets Nod to Trial Respiratory Disease Drug; Shares Up 4%

### [Haisco: Clinical trial approval obtained for new indication of HSK50042 tablet](https://longbridge.com/en/news/277900704.md)
*2026-03-05T08:11:05.000Z*
> Haisco announced that its subsidiary, Shanghai Haisco Shenno Pharmaceutical Technology Co., Ltd., recently received the 

### [Haisco shareholders plan to reduce their holdings by no more than 0.89% of the shares](https://longbridge.com/en/news/274515459.md)
*2026-02-02T12:46:12.000Z*
> Haisco announced that some shareholders holding more than 5%, Hao Congmei and Yang Fei, plan to reduce their holdings by